MYC and neoplasm: Although Chondramide and Myc B are mechanistically distinct (G-actin nucleation inhibitor vs. F-actin severing), it will be interesting to test for changes in TAM content or phenotype in the Myc B treatment groups in our SKOV3 tumor xenograft assays.